title: The association of HLA-DRB1 alleles and drug use with HIV infection in a Chinese Han Cohort.
abstract: OBJECTIVE
  To investigate the relationship between the polymorphism of human leukocyte antigen (HLA)-DRB1 and the susceptibility and repellency of drug use combined with HIV infection in Chinese.
  
  
  METHODS
  A total of 213 unrelated healthy people, 41 HIV-infected drug users, 24 HIV-uninfected drug users, and 64 HIV-infected non-drug users were recruited. Their HLA-DRB1 allele frequencies were analyzed by PCR-SSP and allele distribution was analyzed.
  
  
  RESULTS
  Compared with healthy controls, in drug users, the frequencies of HLA-DRB1 *0401-041, *1001 were significantly higher; in HIV-infected patients, the frequencies of HLA-DRB1 *0101-0103, *0401-0411, *1001 were significantly higher, while the frequencies of DRB1 *1501-1502, *1101-1105, *1301-1302, DRB4, DRB5 were significantly lower; in HIV-infected drug users, the frequencies of HLA-DRB1 *0101-0103, *0401-0411, *0801-0806, *1001, *1401/1404/1405 were significantly higher, while the frequencies of DRB1 *1301/1302, 1501-1502, DRB5 were significantly lower.
  
  
  CONCLUSIONS
  There is close relationship between the polymorphism of HLA-DRB1 alleles and drug use with HIV infection, which plays an important role in elucidating the pathogenesis and providing the basis for therapeutics and prophylaxis of patients with drug use and HIV infection.
authors.affiliation: State Key Laboratory of Virology/Institute of Virology, School of Medicine, Wuhan University, Wuhan, China; Department of Neurosurgery, Wuhan General Hospital Guangzhou Military Region, Wuhan, China.
authors.forename: Bo
authors.initials: B
authors.lastname: Diao
authors.affiliation: Department of Nephrology, Renmin hospital of Wuhan University, Wuhan, China.
authors.forename: Juan
authors.initials: J
authors.lastname: Du
authors.affiliation: Department of Clinical Laboratory, Wuhan General Hospital Guangzhou Military Region, Wuhan, China.
authors.forename: Ying
authors.initials: Y
authors.lastname: Liu
authors.affiliation: State Key Laboratory of Virology/Institute of Virology, School of Medicine, Wuhan University, Wuhan, China.
authors.forename: Fan
authors.initials: F
authors.lastname: Luo
authors.affiliation: State Key Laboratory of Virology/Institute of Virology, School of Medicine, Wuhan University, Wuhan, China. Electronic address: houwei@whu.edu.cn.
authors.forename: Wei
authors.initials: W
authors.lastname: Hou
mesh_terms: D000328:Adult; D000483:Alleles; D044466:Asian People; D016022:Case-Control Studies; D015331:Cohort Studies; D005260:Female; D020022:Genetic Predisposition to Disease; D015658:HIV Infections / Q000209:etiology / Q000235:genetics*; D059811:HLA-DRB1 Chains / Q000235:genetics*; D006801:Humans; D008297:Male; D011110:Polymorphism, Genetic / Q000235:genetics*; D019966:Substance-Related Disorders / Q000150:complications / Q000235:genetics*
chemical_list: D059811:HLA-DRB1 Chains
keywords: Drug use combined with HIV infection; Frequency; HLA-DRB1; Polymorphism
references.citation: Immunogenetics. 2010 Sep;62(9):569-84
references.pmid: 20680261
references.citation: Expert Opin Drug Saf. 2010 May;9(3):431-45
references.pmid: 20078250
references.citation: Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9148-53
references.pmid: 16757563
references.citation: J Infect Dis. 2000 May;181(5):1581-9
references.pmid: 10823757
references.citation: Blood Cells Mol Dis. 2009 Mar-Apr;42(2):129-35
references.pmid: 19054700
references.citation: J Acquir Immune Defic Syndr. 2010 Aug;54(5):447-54
references.pmid: 20463584
references.citation: Endocr Metab Immune Disord Drug Targets. 2011 Mar;11(1):76-89
references.pmid: 21348818
references.citation: Exp Mol Pathol. 2000 Feb;68(1):21-8
references.pmid: 10640451
references.citation: World J Gastroenterol. 2005 Aug 14;11(30):4753-7
references.pmid: 16094724
references.citation: Hepatology. 2011 Aug;54(2):714-23
references.pmid: 21563204
references.citation: Mini Rev Med Chem. 2010 Jul;10(8):746-58
references.pmid: 20394575
references.citation: Cancer Biother Radiopharm. 2011 Apr;26(2):153-7
references.pmid: 21510769
references.citation: Ann N Y Acad Sci. 2005 Apr;1040:301-4
references.pmid: 15891047
references.citation: Mol Oncol. 2011 Apr;5(2):183-9
references.pmid: 21367679
references.citation: Curr Opin Neurol. 2009 Jun;22(3):219-25
references.pmid: 19387341
references.citation: Hepatol Res. 2006 Jun;35(2):118-26
references.pmid: 16890179
references.citation: Br J Dermatol. 2009 Jul;161(1):8-18
references.pmid: 19508304
references.citation: Immunol Rev. 2010 Jan;233(1):62-78
references.pmid: 20192993
references.citation: Brief Funct Genomic Proteomic. 2009 Sep;8(5):379-94
references.pmid: 19468039
references.citation: Occup Environ Med. 2011 Jul;68(7):487-93
references.pmid: 21186201